2
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Phase 4
1
Status
Unknown
1
Completed
1
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Cancer Type
Thoracic
2
Other solid neoplasm
1
Conditions
Lung Diseases
2
Respiratory Aspiration
1
Pulmonary Atelectasis
1
Pneumothorax
1
Pleural Neoplasms
1
Pleural Effusion, Malignant
1
Pleural Diseases
1
Pericardial Effusion
1
Mesothelioma, Malignant
1
Lung Neoplasms
1
Hemothorax
1
Empyema, Pleural
1
Interventions
Carboplatin
1170
Cisplatin
890
Pemetrexed
845
pembrolizumab
624
Paclitaxel
608
Docetaxel
539
Gemcitabine
428
Radiotherapy
390
Erlotinib Hydrochloride
381
Nivolumab
344
Bevacizumab
337
Etoposide
296
durvalumab
264
Drug Therapy
260
osimertinib
236
atezolizumab
224
Radiosurgery
194
Gefitinib
186
Vinorelbine
149
Magnetic Resonance Spectroscopy
131
Ipilimumab
129
130-nm albumin-bound paclitaxel
125
Cetuximab
113
Blood Specimen Collection
106
anlotinib
105
tislelizumab
103
Topotecan
103
Specimen Handling
102
Surgical Procedures, Operative
101
Cyclophosphamide
101
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
One-Lung Ventilation
×
Thoracic
×
Clear all
NCT00534690
2026-05-15
REVOLU
University Hospital, Bordeaux
Phase NA
Completed
88 enrolled
NCT05077111
2021-10-14
VATS
Ain Shams University
Phase 4
Unknown
40 enrolled